* Perrigo Company PLC PRGO.N reported quarterly adjusted
earnings of 53 cents per share for the quarter ended in
January, lower than the same quarter last year, when the company
reported EPS of 63 cents. The mean expectation of
three analysts for the quarter was for earnings of 46 cents per
share. Wall Street expected results to range from 40 cents to 49
cents per share.
* Revenue fell 10.7% to $1.07 billion from a year ago;
analysts
expected $1.13 billion.
* Perrigo Company PLC's reported EPS for the quarter was a
loss
of 79 cents.
* The company reported a quarterly loss of $108.4 million.
* Perrigo Company PLC shares had risen by 9.7% this
quarter and
lost 12.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 18%
in the last three months.
* In the last 30 days, three analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Perrigo Company
PLC is $38.50
This summary was machine generated from LSEG data August 2 at
11:27 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.46 0.53 Beat
Mar. 31 2024 0.23 0.29 Beat
Dec. 31 2023 0.83 0.86 Beat
Sep. 30 2023 0.64